Early Access

10-QPeriod: Q1 FY2024

METLIFE INC Quarterly Report for Q1 Ended Mar 31, 2024

Filed May 2, 2024For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife Inc. reported a strong first quarter for 2024, demonstrating significant year-over-year improvement in key financial metrics. Net income available to common shareholders surged to $800 million, a substantial increase from $14 million in the prior year's first quarter. This growth was driven by a favorable shift in net investment gains and a significant reduction in net derivative losses, alongside improved market conditions impacting market risk benefit remeasurements. Adjusted earnings also saw a healthy increase to $1.33 billion, up from $1.18 billion in Q1 2023, reflecting underlying business performance and favorable market factors. The company maintained a strong capital position and continued its share repurchase program, repurchasing over $1.17 billion in common stock during the quarter. Total assets stood at $677.6 billion at the end of the quarter, with total liabilities of $648.8 billion, resulting in total equity of $28.8 billion. The company's diversified business segments, including Group Benefits, RIS, Asia, Latin America, EMEA, and MetLife Holdings, collectively contributed to this performance, with notable strength observed in the Asia and Latin America segments, driven by volume growth and favorable market conditions, partially offset by foreign currency fluctuations. Looking ahead, MetLife's strategic focus on managing its investment portfolio for long-term value and its robust capital management strategy are expected to support continued financial performance. The company's ability to navigate evolving economic conditions and regulatory landscapes, as evidenced by this quarter's results, positions it well for sustained shareholder value creation. Investors should monitor the company's ongoing progress in its strategic initiatives, its response to market interest rate movements, and its international segment performance.

Financial Statements
Beta
Revenue$16.06B
Operating Expenses$3.22B
Operating Income$1.40B
Net Income$867.00M
EPS (Basic)$1.11
EPS (Diluted)$1.10
Shares Outstanding (Basic)723.20M
Shares Outstanding (Diluted)728.40M

Key Highlights

  • 1MetLife reported a substantial increase in Net Income Available to Common Shareholders to $800 million for Q1 2024, up from $14 million in Q1 2023.
  • 2Adjusted Earnings increased to $1.33 billion in Q1 2024, compared to $1.18 billion in Q1 2023, indicating solid underlying business performance.
  • 3Total Revenues increased to $16.06 billion in Q1 2024 from $15.39 billion in Q1 2023, driven by higher net investment income and premiums.
  • 4Total Expenses decreased to $15.01 billion in Q1 2024 from $15.13 billion in Q1 2023, benefiting from favorable market risk benefit remeasurements.
  • 5The company repurchased approximately $1.17 billion of its common stock during Q1 2024, demonstrating a commitment to returning capital to shareholders.
  • 6Total Assets stood at $677.58 billion as of March 31, 2024, while Total Liabilities were $648.78 billion.
  • 7The company saw strong performance in its Asia and Latin America segments, with adjusted earnings increasing by $143 million and $18 million, respectively, driven by volume growth and favorable market factors.

Frequently Asked Questions